101 related articles for article (PubMed ID: 7034933)
1. Phase I study of high-dose mitomycin with autologous bone marrow support.
Sarna GP; Champlin R; Wells J; Gale RP
Cancer Treat Rep; 1982 Feb; 66(2):277-82. PubMed ID: 7034933
[No Abstract] [Full Text] [Related]
2. Phase I-II study of high-dose mitomycin with autologous bone marrow transplantation in refractory metastatic breast cancer.
Tannir N; Spitzer G; Dicke K; Schell F; DiStefano A; Blumenschein G
Cancer Treat Rep; 1984 May; 68(5):805-6. PubMed ID: 6426793
[No Abstract] [Full Text] [Related]
3. Autologous bone marrow transplantation in neoplasia.
Dicke KA; Vellekoop L; Spitzer G; Zander AR; Schell F; Verma DS
Transplant Proc; 1981 Mar; 13(1 Pt 1):267-9. PubMed ID: 6267751
[No Abstract] [Full Text] [Related]
4. High-dose mitomycin-C with autologous bone marrow transplantation in patients with refractory malignancies. Influence of dose schedule on pharmacokinetics and nonhematopoietic toxicities.
Karanes C; Ratanatharathorn V; Schilcher RB; Young JD; Emmer D; Hoschner JA; Leichman L; Baker LH
Am J Clin Oncol; 1986 Oct; 9(5):444-8. PubMed ID: 3096129
[TBL] [Abstract][Full Text] [Related]
5. Hepatic veno-occlusive disease after high-dose mitomycin C and autologous bone marrow transplantation therapy.
Gottfried MR; Sudilovsky O
Hum Pathol; 1982 Jul; 13(7):646-50. PubMed ID: 6806170
[TBL] [Abstract][Full Text] [Related]
6. Veno-occlusive disease of the liver after high-dose mitomycin C therapy and autologous bone marrow transplantation.
Lazarus HM; Gottfried MR; Herzig RH; Phillips GL; Weiner RS; Sarna GP; Fay J; Wolff SN; Sudilovsky O; Gale RP; Herzig GP
Cancer; 1982 May; 49(9):1789-95. PubMed ID: 7042075
[TBL] [Abstract][Full Text] [Related]
7. Phase I-II study of mitomycin C topical therapy for low-grade, low stage transitional cell carcinoma of the bladder: an interim report.
DeFuria MD; Bracken RB; Johnson DE; Soloway MS; Merrin CE; Morgan LR; Miller HC; Crooke ST
Cancer Treat Rep; 1980; 64(2-3):225-30. PubMed ID: 7407754
[TBL] [Abstract][Full Text] [Related]
8. Phase I study of the combination of iv mitomycin and oral metronidazole.
Pfeffer MR; Sulkes A; Peretz TY; Fuks Z; Catane R
Cancer Treat Rep; 1984 Sep; 68(9):1191-2. PubMed ID: 6478454
[No Abstract] [Full Text] [Related]
9. Mitomycin C: phase I study of a constant infusion ambulatory treatment schedule.
Lokich J; Perri J; Fine N; Bothe A; Nelson T; Greene R; Zipoli T
Am J Clin Oncol; 1982 Aug; 5(4):443-7. PubMed ID: 7113965
[TBL] [Abstract][Full Text] [Related]
10. The use of intensive clinic support to permit outpatient autologous bone marrow transplantation for breast cancer.
Peters WP; Ross M; Vredenburgh JJ; Hussein A; Rubin P; Dukelow K; Cavanaugh C; Beauvais R; Kasprzak S
Semin Oncol; 1994 Aug; 21(4 Suppl 7):25-31. PubMed ID: 7916487
[TBL] [Abstract][Full Text] [Related]
11. [Use of bone marrow transplantation in the treatment of gastric cancer and its evaluation with special reference to anerobic Corynebacterium].
Hattori T; Yagi H; Murakami H; Ushijima K; Mori A
Gan No Rinsho; 1969 Jan; 15(1):39-47. PubMed ID: 4888575
[No Abstract] [Full Text] [Related]
12. Long-term engraftment failure after marrow ablation and autologous hematopoietic reconstitution: differences between peripheral blood stem cell and bone marrow recipients.
Bentley SA; Brecher ME; Powell E; Serody JS; Wiley JM; Shea TC
Bone Marrow Transplant; 1997 Mar; 19(6):557-63. PubMed ID: 9085735
[TBL] [Abstract][Full Text] [Related]
13. High-dose chemotherapy combined with escalating doses of cyclosporin A and an autologous bone marrow transplant for the treatment of drug-resistant solid tumors: a phase I clinical trial.
Stiff PJ; Bayer R; Tan S; Camarda M; Sosman J; Peace D; Kinch L; Rad N; Loutfi S
Clin Cancer Res; 1995 Dec; 1(12):1495-502. PubMed ID: 9815949
[TBL] [Abstract][Full Text] [Related]
14. [From bone marrow transplantation to blood stem cell transplantation. Experiences from the first 100 autologous stem cell transplantation in Turku].
Remes K; Rajamäki A; Grenman S; Itälä M; Kauppila M; Nikoskelainen J; Pelliniemi TT; Ristamäki R; Salmi TT; Salmi T; Salminen E; Vanharanta R; Toivanen A
Duodecim; 1997; 113(3):219-28. PubMed ID: 11370030
[No Abstract] [Full Text] [Related]
15. [High-dose chemotherapy with autologous bone marrow transplantation: 11 years' experience in Zurich].
Jost LM; Honegger HP; Stahel RA
Schweiz Med Wochenschr; 2000 Jan; 130(3):60-9. PubMed ID: 10683881
[TBL] [Abstract][Full Text] [Related]
16. Long-term culture of autologous bone marrow for marrow reconstitution following high-dose chemotherapy. Purging with tumor surface antigen directed human-human monoclonal antibody.
Alonso K; Medenica R; Morehead G
Prog Clin Biol Res; 1994; 389():111-8. PubMed ID: 7700892
[No Abstract] [Full Text] [Related]
17. Phase I trial of high-dose melphalan, high-dose etoposide and autologous bone marrow re-infusion in solid tumors: an Eastern Cooperative Oncology Group (ECOG) study.
Lazarus HM; Gray R; Ciobanu N; Winter J; Weiner RS
Bone Marrow Transplant; 1994 Sep; 14(3):443-8. PubMed ID: 7994270
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of cancer with high-dose chemotherapy and autologous stem cell transplantation].
Geisler CH; Daugaard KG; Dickmeiss E; Ifversen M; Knudsen LM
Ugeskr Laeger; 2003 Dec; 165(50):4846-9. PubMed ID: 14716902
[No Abstract] [Full Text] [Related]
19. Psychological stress symptoms before and after autologous bone marrow transplantation in patients with solid tumors.
Grassi L; Rosti G; Albertazzi L; Marangolo M
Bone Marrow Transplant; 1996 May; 17(5):843-7. PubMed ID: 8733707
[TBL] [Abstract][Full Text] [Related]
20. [High-dose chemotherapy and autologous bone marrow transplantation in solid tumors. A review].
Handberg J; Hansen SW
Ugeskr Laeger; 1996 Jul; 158(29):4175-80. PubMed ID: 8701532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
